Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Does very high LDL particle number with low triglycerides and normal small LDL particles indicate inherited LDL clearance defects?

A profile of very high LDL particle number with low triglycerides and relatively normal small LDL particles is characteristic of monogenic LDL clearance defects such as familial hypercholesterolemia.

SupportedJune 19, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

A pattern of very high LDL particle number with low triglycerides and relatively normal small LDL particles is characteristic of inherited LDL clearance defects such as familial hypercholesterolemia involving LDLR, APOB, or PCSK9.

laying out figure…
All 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim asserts that mutations affecting LDLR, APOB, or PCSK9 produce isolated high LDL-P with low or normal triglycerides and a preserved small LDL count. Mechanistically, impaired hepatic LDL clearance causes accumulation of large, cholesterol-rich LDL rather than triglyceride-driven remodeling into small dense LDL, creating a lipid signature that differentiates inherited clearance defects from metabolic dyslipidemia.

Verified conclusion

Inherited LDL clearance defects, such as familial hypercholesterolemia (FH), present with a distinct lipid profile that reflects the underlying genetic impairment of the LDL receptor (LDLR) pathway.

Clinical and diagnostic evidence

Research indicates that monogenic FH, typically involving mutations in the LDLR, APOB, or PCSK9 genes, is characterized by "isolated hypercholesterolemia." This phenotype is defined by significantly elevated LDL cholesterol (LDL-C) and LDL particle number (LDL-P) alongside normal or low triglyceride levels (<150 mg/dL).

  • Likelihood of Mutation: Clinical studies have demonstrated that patients with this isolated high LDL/low triglyceride phenotype have a significantly higher probability of harboring a monogenic mutation compared to those with elevated triglycerides.
  • Particle Size Differentiation: In monogenic FH, the LDL particles are typically large and buoyant. This contrasts with common polygenic hypercholesterolemia or metabolic syndrome, where small, dense LDL (sdLDL) particles predominate. Consequently, a profile showing high LDL-P with a relatively normal small LDL count is a hallmark of an inherited clearance defect rather than metabolic dyslipidemia.

Mechanistic explanations

The characteristic lipid pattern is a direct consequence of the molecular pathology of FH:

  • Impaired Clearance: The primary defect in FH is the inability of the liver to remove LDL from the blood. Mutations in LDLR reduce receptor activity, APOB mutations impair the binding of LDL to the receptor, and PCSK9 mutations lead to increased degradation of the receptor itself.
  • Absence of Remodeling: In metabolic dyslipidemias, high triglycerides trigger the exchange of lipids between VLDL and LDL, followed by lipase-mediated hydrolysis, which creates small, dense LDL particles. In monogenic FH, because triglyceride levels are typically low and the defect is specific to LDL clearance rather than overproduction of triglyceride-rich lipoproteins, this remodeling process does not occur. The result is an accumulation of "virgin" large LDL particles that stay in circulation longer due to the clearance defect.

Bottom line

A lipid profile showing high LDL-P, low triglycerides, and normal levels of small LDL particles is scientifically supported as a characteristic signature of monogenic familial hypercholesterolemia. This pattern serves as a critical clinical marker to differentiate inherited clearance defects from polygenic or metabolic causes of high cholesterol.

References

  1. Abstract 4365858: Genetic Evaluation of Familial Hypercholesterolemia in a Pediatric Cardiology Clinic — ahajournals.org ↗
  2. Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia. — tandfonline.com ↗
  3. Variants of uncertain significance in the genetic diagnosis of heterozygous familial hypercholesterolemia — htn.almazovcentre.ru ↗
  4. Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype — pmc.ncbi.nlm.nih.gov ↗
  5. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE. — linkinghub.elsevier.com ↗
  6. Clinical, Anthropometric and Biochemical Characteristics of Patients with or without Genetically Confirmed Familial Hypercholesterolemia — scielo.br ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→